Xenon Pharms

XENE NASDAQ
9.56
0.00
0.00%
盘后: 9.56 0 0.00% 18:07 06/25 EDT
开盘
9.60
昨收
9.56
最高
9.78
最低
9.51
成交量
6.29万
成交均量(3M)
9.20万
52周最高
15.92
52周最低
5.41
换手率
0.24%
市值
2.46亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Xenon Pharms XENE股票价格,Xenon Pharms股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Xenon Pharmaceuticals Inc is a Canada-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its product pipeline includes: Glybera, TV-45070, GDC-0310, XEN901 (Nav1.6 inhibitor) and XEN1101. Glybera is used for the treatment of lipoprotein lipase deficiency (LPLD). Specifically, it is intended to treat LPLD in patients with severe or multiple pancreatitis attacks, despite dietary fat restrictions. TV-45070 is a small-molecule inhibitor of the sodium channel Nav1.7 and other sodium channels, including those that are expressed in the pain-sensing peripheral nervous system. XEN901 is developed for the treatment of rare infantile epileptic encephalopathy and other forms of epilepsy. XEN1101, is a potassium channel modulator for the treatment of epilepsy. Its Extreme Genetics discovery platform enables the Company to identify drug targets that are more biologically relevant in humans.
展开 >

最近浏览

名称
价格
涨跌幅